A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 10 January 2018 |
| Author/s |
author: Talal Hilal Allison C Rosenthal Mohamad Bassam Sonbol Amylou Dueck |
| Publication date | January 10, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |